NORTHGENE LIMITED

Active Deeside

Other human health activities

0 employees website.com
Other human health activities
N

NORTHGENE LIMITED

Other human health activities

Founded 30 Mar 1994 Active Deeside, Wales 0 employees website.com
Other human health activities

Previous Company Names

OKASTEP LIMITED 30 Mar 1994 — 10 May 1994
Accounts Submitted 12 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 31 Mar 2026 Next due 13 Apr 2027 11 months remaining
Net assets £100 £0 2024 year on year
Total assets £100 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

2 Tenth Avenue Deeside Industrial Park Deeside CH5 2UA Wales

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NORTHGENE LIMITED (02914392), an active company based in Deeside, Wales. Incorporated 30 Mar 1994. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Net Assets

£100.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Leaves, Nicholas Ivor, DrDirectorBritishEngland5830 Nov 2018Active

Shareholders

Shareholders (1)

Compass Bioscience Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 30 Nov 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

NORTHGENE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
31 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-30 with no updates
20 Jan 2026OfficersChange to director Mr Nicholas Watson Ash on 2026-01-01
12 Dec 2025AccountsAnnual accounts made up to 2025-03-31
10 Apr 2025Confirmation StatementConfirmation statement made on 2025-03-30 with no updates
19 Dec 2024AccountsAnnual accounts made up to 2024-03-31
31 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-30 with no updates

20 Jan 2026 Officers

Change to director Mr Nicholas Watson Ash on 2026-01-01

12 Dec 2025 Accounts

Annual accounts made up to 2025-03-31

10 Apr 2025 Confirmation Statement

Confirmation statement made on 2025-03-30 with no updates

19 Dec 2024 Accounts

Annual accounts made up to 2024-03-31

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-30 with no updates

3 weeks ago on 31 Mar 2026

Change to director Mr Nicholas Watson Ash on 2026-01-01

3 months ago on 20 Jan 2026

Annual accounts made up to 2025-03-31

4 months ago on 12 Dec 2025

Confirmation statement made on 2025-03-30 with no updates

1 years ago on 10 Apr 2025

Annual accounts made up to 2024-03-31

1 years ago on 19 Dec 2024